A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's Disease

Completed · Phase 2

Conditions studied: Parkinsonian Syndrome

In brief

This study involves study participants who have been clinically diagnosed with parkinsonian syndrome or who are at-risk for parkinsonian syndrome, have a family history of parkinsonian syndrome or exposure to environmental toxins potentially associated with parkinsonian syndrome. Participants will have brain imaging to assess dopamine transporter density. The imaging data coupled with family history and environmental exposure data may provide important information about potential risk factors for parkinsonian syndrome.

Key facts

Study ID

NCT00117819

Run by

Institute for Neurodegenerative Disorders

People needed

232

Starts

2001-03-01

Expected to finish

2013-01-01

Last updated by the study team

2014-05-02

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 22 years or older
• A clinical diagnosis of Parkinson's disease (PD), positive family history of PD and/or potential exposure to environmental toxins
• Normal screening laboratory studies

You may not qualify if…

• Pregnancy
• Psychiatric disease other than history of depression
• Significant medical disease including abnormalities on screening

Where it is running

• Institute for Neurodegenerative Disorders — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.